Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |